2024-04-19  9:13:36 PM Chg. +0.04 Volume Bid9:58:00 PM Ask9:58:00 PM Market Capitalization Dividend Y. P/E Ratio
10.66EUR +0.38% 9,699
Turnover: 100,940.66
10.40Bid Size: 300 10.68Ask Size: 1,000 2.23 bill.EUR - 24.19

Business description

SYNLAB Group is the largest European clinical laboratory and medical diagnostic services provider by revenue and number of tests. SYNLAB offers a full range of innovative and reliable medical diagnostics for patients, practising doctors, clinics and the pharmaceutical industry. Providing the leading level of service within the industry, SYNLAB is the partner of choice for diagnostics in human and veterinary medicine. The Group continuously innovates medical diagnostic services for the benefit of patients and customers.
 

Management board & Supervisory board

CEO
Mathieu Floreani
Management board
Sami Badarani, Robert Steinwander, Dr Santiago Valor, Luis Vieira, Henrik Andreasen, Catharina Monster, Dr Fabian Walla
Supervisory board
Prof Dr David Ebsworth, Barbara Lambert, Dr Bartl Wimmer, Alex Leslie, Anastasya Molodykh-McFarlane, Christian Salling, Karin Bierstedt, Dr Stefan Graf, Dr Ute Hasholzner, Rene Schmidt-Ferroud, Marc Welters, Iris Schopper
 

Company data

Name: SYNLAB AG
Address: Moosacher Straße 88,D-80809 München
Phone: +49-89-307-602-0
Fax: -
E-mail: info@synlab.com
Internet: https://www.synlab.de/
Industry: Healthcare
Sector: Healthcare Providers
Sub sector: Healthcare Providers
End of financial year: 12-31
Free Float: -
IPO date: -

Investor relations

Name: -
IR phone: +49 89 307602-0
IR Fax: -
IR e-mail: ir@synlab.com

Company calendar

CW 19 | 2024-05-08 Interim Report 1st Quarter/3 Months
CW 20 | 2024-05-17 General Shareholder Meeting
CW 32 | 2024-08-08 Interim Report 2nd Quarter/6 Months
CW 45 | 2024-11-07 Interim Report 3rd Quarter/9 Months
 

Main Shareholders

Cinven
 
43.00%
free float
 
19.00%
Novo
 
19.00%
OTPP
 
9.00%
QIA
 
5.00%
Elliott
 
5.00%